isoxazoles has been researched along with Male Genitourinary Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batteiger, BE; Hook, EW; Johnson, SM; Kwak, H; Lawrence, K; Long, J; Marrazzo, J; Mueller, J; Seña, AC; Taylor, SN; Wierzbicki, MR | 1 |
1 trial(s) available for isoxazoles and Male Genitourinary Diseases
Article | Year |
---|---|
Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Barbiturates; Ceftriaxone; Female; Female Urogenital Diseases; Gonorrhea; Humans; Injections, Intramuscular; Intention to Treat Analysis; Isoxazoles; Male; Male Urogenital Diseases; Microbial Sensitivity Tests; Middle Aged; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Pharyngeal Diseases; Rectal Diseases; Sexual Partners; Spiro Compounds; Treatment Outcome; Young Adult | 2018 |